Oncology & Cancer

SABCS: PD 0332991 + letrozole studied in ER+ breast cancer

(HealthDay)—For women with estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, the investigational agent PD 0332991 plus letrozole improves progression-free survival versus ...

Oncology & Cancer

Exercise improves quality of life during breast cancer treatment

Women undergoing treatment for breast cancer might fight off distressing side effects and improve psychological well-being by staying off the couch. According to the University of Miami (UM) study, women who are physically ...

page 29 from 30